Skip to main content

Table 1 Differential cell counts (percentages) in the bronchoalveolar lavage fluid after treatment with PBS or OVA inhalation and subcutaneous injection of 4T1 cells

From: Asthma-related inflammation promotes lung metastasis of breast cancer cells through CCL11–CCR3 pathway

Differential cell counts
n = 8 INH INH + 4T1 subcutaneous injection
Cell type PBS OVA PBS OVA
Eosinophils 3.53 ± 0.39 29.5 ± 5.74 11 ± 1.86 17.3 ± 5.15
Neutrophils 6.1 ± 1.43 5.46 ± 1.39 27.35 ± 1.74 46.31 ± 5.16**
Lymphocytes 0.10 ± 0.10 0.0 ± 0.0 0.0 ± 0.0 0.77 ± 0.43
Epithelial cells 5.83 ± 1.93 5.13 ± 1.72 1.62 ± 0.69 2.81 ± 0.97
Macrophages 84.3 ± 2.8 59.7 ± 4.3* 59.9 ± 2.76 32.63 ± 6.6**
Proteins level expression of CCL11
n = 8 INH INH + 4T1 subcutaneous injection
CCL11 (pg/ml) PBS OVA PBS OVA
Mean ± SEM 0,21 ± 0,04 0,58 ± 0,12* 0,36 ± 0,07 0,42 ± 0,08
  1. Proteins level expression of CCL11 (pg/ml) in lung of mice exposed to PBS or OVA and subcutaneously injected with 4T1 cells. *p < 0.05, **p < 0.01.
\